These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21903941)

  • 1. Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis.
    Quillard T; Tesmenitsky Y; Croce K; Travers R; Shvartz E; Koskinas KC; Sukhova GK; Aikawa E; Aikawa M; Libby P
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2464-72. PubMed ID: 21903941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I.
    Reimers GJ; Jackson CL; Rickards J; Chan PY; Cohn JS; Rye KA; Barter PJ; Rodgers KJ
    Cardiovasc Res; 2011 Jul; 91(1):37-44. PubMed ID: 21354994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-13 predominates over matrix metalloproteinase-8 as the functional interstitial collagenase in mouse atheromata.
    Quillard T; Araújo HA; Franck G; Tesmenitsky Y; Libby P
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1179-86. PubMed ID: 24723558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice.
    Li B; Zhao Y; Liu H; Meng B; Wang J; Qi T; Zhang H; Li T; Zhao P; Sun H; Xu J; Song H; Dong Z; An F
    PLoS One; 2016; 11(2):e0148273. PubMed ID: 26848572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype.
    Cheng C; Tempel D; van Haperen R; van Damme L; Algür M; Krams R; de Crom R
    Atherosclerosis; 2009 May; 204(1):26-33. PubMed ID: 19233360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques.
    Schneider F; Sukhova GK; Aikawa M; Canner J; Gerdes N; Tang SM; Shi GP; Apte SS; Libby P
    Circulation; 2008 Feb; 117(7):931-9. PubMed ID: 18250269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice.
    Johnson JL; Devel L; Czarny B; George SJ; Jackson CL; Rogakos V; Beau F; Yiotakis A; Newby AC; Dive V
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):528-35. PubMed ID: 21212406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice.
    Nencioni A; da Silva RF; Fraga-Silva RA; Steffens S; Fabre M; Bauer I; Caffa I; Magnone M; Sociali G; Quercioli A; Pelli G; Lenglet S; Galan K; Burger F; Vázquez Calvo S; Bertolotto M; Bruzzone S; Ballestrero A; Patrone F; Dallegri F; Santos RA; Stergiopulos N; Mach F; Vuilleumier N; Montecucco F
    Thromb Haemost; 2014 Feb; 111(2):308-22. PubMed ID: 24196571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cartilage oligomeric matrix protein (COMP) in murine brachiocephalic and carotid atherosclerotic lesions.
    Bond AR; Hultgårdh-Nilsson A; Knutsson A; Jackson CL; Rauch U
    Atherosclerosis; 2014 Oct; 236(2):366-72. PubMed ID: 25133350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice.
    Moustardas P; Kadoglou NP; Katsimpoulas M; Kapelouzou A; Kostomitsopoulos N; Karayannacos PE; Kostakis A; Liapis CD
    PLoS One; 2014; 9(9):e108240. PubMed ID: 25264981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques.
    Deguchi JO; Aikawa E; Libby P; Vachon JR; Inada M; Krane SM; Whittaker P; Aikawa M
    Circulation; 2005 Oct; 112(17):2708-15. PubMed ID: 16230484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.
    Akhtar S; Gremse F; Kiessling F; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):679-86. PubMed ID: 23393393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
    Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-24 regulates macrophage behavior and retards atherosclerosis.
    Di Gregoli K; Jenkins N; Salter R; White S; Newby AC; Johnson JL
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1990-2000. PubMed ID: 24990232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging.
    Chang K; Francis SA; Aikawa E; Figueiredo JL; Kohler RH; McCarthy JR; Weissleder R; Plutzky J; Jaffer FA
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1933-9. PubMed ID: 20689078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonodynamic therapy suppresses matrix collagen degradation in vulnerable atherosclerotic plaque by modulating caspase 3 - PEDF/HIF-1α - MMP-2/MMP-9 signaling in macrophages.
    Tian Y; Sheng S; Gao W; Yao J; Tian Y
    PLoS One; 2022; 17(12):e0279191. PubMed ID: 36574366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.